Nora B Henrikson1, William J Ellis, Donna L Berry. 1. University of Washington School of Public Health and Community Medicine, Institute for Public Health Genetics, Seattle, WA 98195, USA. nhenriks@u.washington.edu
Abstract
OBJECTIVE: To explore whether reversibility, decision timing, and uncertainty are relevant to men deciding on treatment for localized prostate cancer (LPC). DESIGN: Secondary qualitative data analysis of unstructured interviews. METHODS: Content analysis of previously collected qualitative data (31 individual interviews, 5 focus groups). We identified the frequency of references to reversibility, decision timing, and uncertainty and related sub-themes. RESULTS: We identified eight themes: reversibility, timing of decision, number of options, "getting it over with," "the way I make decisions," uncertainty among experts, desire for certainty, and probability. Fifteen men mentioned reversibility in individual interviews; 13 mentioned the importance of the timing of their decision. Eleven mentioned the importance of the number of options; twelve "the way I make decisions." Eleven men mentioned the uncertainty of experts, fourteen the desire to "get it over with," and six a desire for certainty. CONCLUSION: This study provides compelling preliminary data suggesting that men consider the reversibility, decision timing, and uncertainty in the prostate cancer treatment decision. PRACTICE IMPLICATION: These findings may be helpful in enhancing support for men facing the treatment decision.
OBJECTIVE: To explore whether reversibility, decision timing, and uncertainty are relevant to men deciding on treatment for localized prostate cancer (LPC). DESIGN: Secondary qualitative data analysis of unstructured interviews. METHODS: Content analysis of previously collected qualitative data (31 individual interviews, 5 focus groups). We identified the frequency of references to reversibility, decision timing, and uncertainty and related sub-themes. RESULTS: We identified eight themes: reversibility, timing of decision, number of options, "getting it over with," "the way I make decisions," uncertainty among experts, desire for certainty, and probability. Fifteen men mentioned reversibility in individual interviews; 13 mentioned the importance of the timing of their decision. Eleven mentioned the importance of the number of options; twelve "the way I make decisions." Eleven men mentioned the uncertainty of experts, fourteen the desire to "get it over with," and six a desire for certainty. CONCLUSION: This study provides compelling preliminary data suggesting that men consider the reversibility, decision timing, and uncertainty in the prostate cancer treatment decision. PRACTICE IMPLICATION: These findings may be helpful in enhancing support for men facing the treatment decision.
Authors: D Feldman-Stewart; M D Brundage; C Hayter; P Groome; J C Nickel; H Downes; W J Mackillop Journal: Med Decis Making Date: 2000 Jan-Mar Impact factor: 2.583
Authors: Donna L Berry; William J Ellis; Nancy Fugate Woods; Christina Schwien; Kristin H Mullen; Claire Yang Journal: Urol Oncol Date: 2003 Mar-Apr Impact factor: 3.498
Authors: Kathryn L Taylor; Richard M Hoffman; Kimberly M Davis; George Luta; Amethyst Leimpeter; Tania Lobo; Scott P Kelly; Jun Shan; David Aaronson; Catherine A Tomko; Amy J Starosta; Charlotte J Hagerman; Stephen K Van Den Eeden Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-06-02 Impact factor: 4.254
Authors: Lindsey Reichlin; Nithya Mani; Kara McArthur; Amy M Harris; Nithin Rajan; Clifford C Dacso Journal: J Med Internet Res Date: 2011-01-12 Impact factor: 5.428
Authors: Susan C Pitt; Megan C Saucke; Elizabeth M Wendt; David F Schneider; Jason Orne; Cameron L Macdonald; Nadine P Connor; Rebecca S Sippel Journal: Thyroid Date: 2020-11-04 Impact factor: 6.568